A patient with newly diagnosed lung cancer and suspected metastasis to the liver and adrenal glands is experiencing fatigue and mild anemia. Considering the patient's condition and the laboratory findings, what is the priority nursing intervention?

B) Administer prescribed oxygen therapy to improve respiratory function and reduce fatigue.

A) Encourage the patient to increase iron-rich foods in their diet to address the anemia.

B) Administer prescribed oxygen therapy to improve respiratory function and reduce fatigue.

C) Educate the patient about energy conservation techniques to manage fatigue.

D) Arrange a consultation with a dietitian to assess nutritional needs.

A patient with newly diagnosed lung cancer is found to have a 4 cm mass in the right upper lobe, suspicious nodules in the left lung, and enlarged mediastinal lymph nodes. Diagnostic results include a PET scan showing increased metabolic activity in the adrenal glands and liver, elevated carcinoembryonic antigen (CEA), and mild anemia. As a nurse, what is the priority nursing intervention when planning care for this patient?

B) Assess the patient's respiratory status and oxygen saturation levels regularly to monitor for potential hypoxia.

A) Educate the patient about the importance of adhering to chemotherapy schedules to reduce tumor burden.

B) Assess the patient's respiratory status and oxygen saturation levels regularly to monitor for potential hypoxia.

C) Coordinate with the dietitian to ensure the patient receives adequate nutritional support to address anemia.

D) Discuss with the patient and family about advance care planning and palliative care options.

A patient with progressive lung cancer presents with increased shortness of breath, cough, weight loss, pleural effusion, worsening anemia, elevated liver enzymes, and hyponatremia. Which nursing intervention is the priority to address the patient's immediate needs?

D) Perform thoracentesis to alleviate pleural effusion and improve respiratory function.

A) Administer supplemental oxygen to manage hypoxia.

B) Educate the patient and family about potential dietary changes to manage hyponatremia.

C) Coordinate with the oncology team to adjust the chemotherapy regimen.

D) Perform thoracentesis to alleviate pleural effusion and improve respiratory function.

A patient with advanced lung cancer and recent progression of disease presents with increased shortness of breath, a persistent cough, and noticeable weight loss. A chest CT reveals a moderate right-sided pleural effusion, and laboratory results show worsening anemia and hyponatremia. Which nursing intervention should be prioritized to address the patient's immediate respiratory needs?

C) Prepare the patient for thoracentesis to relieve pleural effusion.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Encourage deep breathing exercises to enhance lung expansion.

C) Prepare the patient for thoracentesis to relieve pleural effusion.

D) Administer a diuretic to manage fluid overload.

A patient who recently underwent thoracentesis is now presenting with low-grade fever, tachycardia, hypotension, and confusion. The nurse is aware that these symptoms may indicate sepsis. What is the most appropriate initial nursing intervention?

B) Initiate a rapid fluid resuscitation protocol

A) Administer prescribed broad-spectrum antibiotics immediately

B) Initiate a rapid fluid resuscitation protocol

C) Place the patient in a semi-Fowler's position to improve respiratory effort

D) Obtain a stat electrocardiogram (ECG) to assess cardiac function

A patient, post-thoracentesis, develops signs of potential sepsis and worsening anemia. Considering the patient's current condition and history, which nursing intervention is the most critical to prioritize?

A) Administering the ordered broad-spectrum antibiotics

B) Starting hypertonic saline infusion to correct hyponatremia

C) Monitoring liver function tests for any further elevation

D) Discussing palliative care options with the patient and family

A patient with known liver metastasis and recent positive blood cultures for Staphylococcus aureus presents with confusion and fluctuating sodium levels. Which nursing intervention is most appropriate to address the patient's current clinical status?

A) Administering prescribed hypertonic saline to correct hyponatremia

B) Encouraging increased oral fluid intake to manage dehydration

C) Initiating a low-sodium diet to prevent further electrolyte imbalance

D) Withholding antibiotics until the confusion resolves

A patient with a confirmed Staphylococcus aureus infection and hepatic metastasis presents with fluctuating confusion and persistent fever despite targeted antibiotic therapy. What is the nurse's priority intervention to address the patient's current condition?

A) Increase the frequency of neurological assessments to monitor for worsening hepatic encephalopathy.

B) Collaborate with the healthcare team to adjust the antibiotic regimen based on the latest culture results.

C) Administer antipyretics to manage the persistent fever and ensure patient comfort.

D) Initiate discussions with the patient and family about palliative care options to align treatment with their goals.

A patient with advanced cancer is exhibiting signs of respiratory distress, renal dysfunction, and neurological impairment. Based on the clinical scenario, what is the priority nursing intervention to address the patient's current condition?

A) Increase the rate of supplemental oxygen to improve oxygen saturation.

B) Prepare the patient for continuous renal replacement therapy (CRRT) to manage fluid overload.

C) Administer a bronchodilator to alleviate respiratory distress.

D) Conduct a family meeting to discuss the patient's prognosis and care preferences.

A patient with advanced cancer is experiencing worsening respiratory distress, renal dysfunction, and neurological compromise. Given the current clinical findings, which immediate nursing action is most appropriate to address the patient's respiratory status?

B) Prepare for endotracheal intubation and mechanical ventilation.

A) Increase the flow rate of supplemental oxygen to improve saturation levels.

B) Prepare for endotracheal intubation and mechanical ventilation.

C) Administer a diuretic to reduce pulmonary edema.

D) Elevate the head of the bed to 45 degrees to facilitate breathing.

Akciger kanseri - Nursing Case Study

Pathophysiology

• Primary mechanism: Lung cancer primarily arises from genetic mutations in lung epithelial cells, often triggered by carcinogens like tobacco smoke, which cause DNA damage and disrupt normal cell cycle regulation, leading to uncontrolled cell proliferation.

• Secondary mechanism: Tumor angiogenesis is crucial for cancer growth, involving the secretion of vascular endothelial growth factor (VEGF) by cancer cells, which stimulates the formation of new blood vessels to supply the tumor with nutrients and oxygen.

• Key complication: Metastasis is a critical concern, as malignant cells can invade surrounding tissues and spread via the bloodstream or lymphatic system to distant organs, significantly impacting prognosis and treatment options.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Chronic obstructive pulmonary disease (COPD), hypertension

• Current medications: Albuterol inhaler, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and difficulty breathing

• Key symptoms: Weight loss, chest pain, fatigue, hemoptysis

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to proceed with further diagnostic testing to clarify the extent of the lung cancer and evaluate for any metastatic spread. A chest CT scan revealed a 4 cm mass in the right upper lobe with signs of invasion into the pleura, raising concerns about local advancement. Additionally, there were several small nodules in the left lung and enlarged mediastinal lymph nodes, suggesting potential metastasis. A PET scan was ordered, which highlighted increased metabolic activity not only in the primary lung mass but also in the adrenal glands and liver, indicating likely metastatic disease.

Laboratory tests showed elevated levels of carcinoembryonic antigen (CEA), a tumor marker often associated with lung cancer. Blood work also revealed mild anemia with a hemoglobin level of 11.5 g/dL, which could be contributing to the patient's fatigue. Liver function tests were slightly abnormal, with elevated alanine transaminase (ALT) and aspartate transaminase (AST), potentially reflecting liver involvement by metastatic disease. These findings suggest a complex clinical picture that requires a multidisciplinary approach to manage both local and systemic manifestations of the disease.

The healthcare team is now faced with critical decisions regarding the management plan, taking into account the patient's overall health status, comorbid conditions like COPD and hypertension, and the extent of cancer spread. The next steps involve discussing potential treatment modalities such as chemotherapy, targeted therapy, or palliative care options with the patient and his family, considering his quality of life and treatment goals. These discussions will guide the ongoing care strategy and address the patient's symptoms, aiming to improve his respiratory function and manage pain effectively.

Section 2

Following the comprehensive diagnostic workup, the healthcare team initiated treatment with a combination of chemotherapy and targeted therapy tailored to the patient's specific cancer profile. However, within a few weeks, the patient began to exhibit new complications, highlighting the aggressive nature of his disease. He presented to the clinic with increased shortness of breath, a persistent cough, and noticeable weight loss. Physical examination revealed decreased breath sounds on the right side and dullness to percussion, suggestive of a pleural effusion, likely due to the invasion of the pleura by the tumor.

A repeat chest CT confirmed a moderate right-sided pleural effusion and an increase in the size of the primary lung mass, indicating disease progression despite initial treatment. Additionally, the patient's lab results showed worsening anemia, with hemoglobin dropping to 9.8 g/dL, and further elevation in liver enzymes (ALT: 85 IU/L, AST: 90 IU/L), raising concerns about advancing liver metastasis. Electrolyte imbalances were also noted, with hyponatremia (Na: 130 mmol/L) potentially due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), a paraneoplastic syndrome associated with lung cancer.

These developments required immediate clinical reasoning to prioritize interventions. Thoracentesis was performed to alleviate the pleural effusion and improve respiratory function, providing symptomatic relief. The oncology team discussed the need to adjust the treatment regimen, considering potential resistance to the current therapy and the patient's declining functional status. This situation underscores the importance of ongoing assessment and dynamic management strategies in complex cancer cases, emphasizing the need to balance aggressive treatment with quality of life considerations. As the team navigates these challenges, discussions with the patient and family about goals of care and potential palliative approaches become increasingly critical.

Section 3

As the team continued to monitor the patient's condition following the thoracentesis, his respiratory status showed temporary improvement, with reduced shortness of breath and lessened cough. However, within days, new complications emerged that required immediate attention. The patient developed a low-grade fever, reaching 38.2°C (100.8°F), along with increased fatigue and confusion. His vital signs indicated tachycardia with a heart rate of 112 bpm and hypotension, with blood pressure dropping to 88/56 mmHg, suggesting possible sepsis or worsening anemia.

Laboratory workup revealed a further decline in hemoglobin levels to 8.5 g/dL, exacerbating his anemia. Blood cultures were ordered to rule out an infectious process, and empiric broad-spectrum antibiotics were initiated while awaiting results. Additionally, liver function tests showed continued elevation, with ALT now at 110 IU/L and AST at 115 IU/L, indicating ongoing hepatic stress, possibly related to metastasis or drug-induced liver injury. The sodium level remained low at 128 mmol/L, confirming persistent hyponatremia, and a decision was made to administer hypertonic saline cautiously to correct this imbalance.

The patient's condition necessitated a multidisciplinary meeting to reassess his treatment plan. The team considered modifying his chemotherapy regimen, taking into account his declining performance status and the potential need for supportive care measures. Conversations with the patient and his family focused on understanding his wishes and exploring palliative care options to enhance his quality of life. This evolving situation required careful clinical reasoning to determine the most appropriate interventions, balancing aggressive cancer treatment against the potential benefits of a more conservative approach.

Section 4

The initial assessment findings revealed that the patient, while still experiencing episodes of confusion, was oriented to person but not to place or time. His respiratory examination showed increased crackles at the lung bases, suggestive of fluid accumulation or possible infection, warranting close observation for potential respiratory compromise. The abdomen was soft, but the liver edge was palpable, indicating hepatomegaly, which raised concerns about worsening liver metastasis. Neurological examination uncovered slight tremors in the hands, possibly linked to his low sodium levels or hepatic encephalopathy. The patient's skin appeared pallid, consistent with his anemia, but there was no jaundice, which would suggest more severe liver dysfunction.

New diagnostic results provided further insight into his deteriorating condition. The blood cultures returned positive for Staphylococcus aureus, confirming a septic process likely originating from a hospital-acquired infection, possibly through a central line. In line with this finding, the patient's antibiotic regimen was adjusted to a more targeted approach based on sensitivity results. Additionally, a chest X-ray confirmed the presence of pleural effusion; however, it was less pronounced than before, indicating that the thoracentesis had a temporary effect. An abdominal ultrasound was performed, revealing multiple hepatic lesions, supporting the hypothesis of metastatic spread contributing to his liver dysfunction.

The patient's response to the interventions was monitored closely. While there was a slight improvement in his sodium levels, indicating some success with the hypertonic saline, his overall clinical status remained fragile. Despite the targeted antibiotic therapy, his fever persisted, and his confusion fluctuated, hinting at a complex interplay of infection, electrolyte imbalance, and hepatic complications. The healthcare team faced a critical juncture, needing to decide whether to intensify supportive measures or to pivot towards a palliative focus, aligning treatment with the patient's goals and prioritizing comfort. This crucial decision would shape the next phase of his journey, emphasizing the need for holistic, patient-centered care.

Section 5

As the healthcare team continued to monitor the patient, new complications began to emerge, requiring immediate attention and a re-evaluation of the treatment strategy. Over the next 48 hours, the patient developed increasing respiratory distress, characterized by tachypnea with a respiratory rate consistently above 30 breaths per minute and a decline in oxygen saturation, now hovering around 88% on supplemental oxygen. Auscultation revealed worsening crackles throughout both lung fields, suggesting further fluid accumulation or progression of infection. Arterial blood gas analysis showed respiratory acidosis with a pH of 7.33, pCO2 of 60 mmHg, and HCO3 of 28 mEq/L, indicative of impaired gas exchange and impending respiratory failure.

Simultaneously, the patient's renal function began to deteriorate. Serum creatinine rose from baseline 1.2 mg/dL to 2.3 mg/dL, and blood urea nitrogen increased to 45 mg/dL, raising concerns about acute kidney injury possibly secondary to sepsis, dehydration, or medication effects. This was compounded by a drop in urine output to less than 400 mL over 24 hours. Given the complexity of his condition, the interdisciplinary team explored the possibility of initiating renal support with continuous renal replacement therapy (CRRT) to manage fluid overload and support renal function while preventing further electrolyte disturbances.

Clinically, the patient's confusion worsened, and he became increasingly lethargic, with episodes of agitation interspersed with periods of somnolence. His Glasgow Coma Scale score fluctuated between 10 and 12, reflecting significant neurological compromise. The healthcare team recognized the need for a multidimensional approach, balancing aggressive treatment of reversible conditions with the reality of his advanced cancer. This necessitated a family meeting to discuss prognosis, potential interventions, and alignment with the patient's values and goals, ensuring that care remained compassionate and centered on quality of life.